Abstract

MEDEROS CURBELO, Orestes N.; ROMERO DIAZ, Carlos A.; BARRERA ORTEGA, Juán C.  and  CANTERO RONQUILLO, Alexis. Malignant tumor of the granulose (stroma) of the ovaries showing a survival rate of 20 years under a combined treatment. Rev Cubana Obstet Ginecol [online]. 2006, vol.32, n.3, pp. 0-0. ISSN 1561-3062.

This paper presented a patient seen for the first time at the age of 37, with a long survival period of over 20 years, despite the fact that she suffered from a malignant tumor of the granulose membrane of the ovaries treated in a combined way with surgery and neoadjuvant and adjuvant treatment of polychemotherapy. It should be underlined that Dr Silvano Reyes Fuentes, Full professor of Gynecology and Obstetrics, permanently participated in the follow-up of this case; he is an example of dedication and love to this specialty and therefore, we devote the present paper to him, with the due respect and admiration that we extended when he was alive. The first surgery was total abdominal hysterectomy with double adnexectomy but in spite of a combined treatment applied with cytostatics, she presented with several episodes of tumoral relapses in the abdominal wall, vaginal cupula, sigmoid, bladder and liver and required 5 more surgical resections. The first one was performed by Professor Reyes Fuentes and the rest of them by our team, which combined these procedures with adjuvant treatment of polychemotherapy, thus achieving tumor-free periods; the relapses have been reduced in the course of time and at present this patient is asymptomatic. The willingness, modesty and vision of team medicine of Dr Silvano Reyes Fuentes , Full professor of Gynecology and Obstetrics, together with the fact that a right decision was made for each situation yielded the result of a long survival in a patient with an aggressive oncological lesion tending to relapse, all of which proves that multidisciplinary teamwork is determining in achieving good results as to survival.

Keywords : tumor relapse; neoadjuvant treatment; adjuvant; polychemotherapy.